MA vs XBIO · P/E 38, rev $17.68B vs rev $1.5M
Mastercard Inc (MA) versus Xenetic Biosciences Inc (XBIO) — a side-by-side from cached financials, not a winner call.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Xenetic Biosciences Inc (XBIO) is a biotechnology company listed on US.
Latest reported MA revenue for 2026-06-30 was $17.68B. Net income was $8.27B. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Latest reported XBIO revenue for 2026-06-30 was $1.5M. Net income was -$1.4M. Revenue was up 81.9% from 2026-03-31 to 2026-06-30. XBIO currently screens at market cap $5.7M.
MA currently screens at market cap $515.12B and trailing P/E 38.4. XBIO currently screens at market cap $5.7M.
Not investment advice. Open the MA and XBIO stock pages for the full models.
Not investment advice.